Ontogeny of glucagon-like immunoreactive peptides in rat intestine

Regulatory Peptides
|June 1, 1987
PubMed

Insights

The fetal rat intestine develops glucagon-like peptides (GLP) between 17 and 19 days of gestation. This study tracked GLP levels, finding significant increases and maturation during this critical developmental window.

Area of Science:

  • Developmental Biology
  • Endocrinology
  • Gastroenterology

Background:

  • Intestinal glucagon-like peptides (GLP) play crucial roles in metabolic regulation.
  • Understanding the ontogeny of these peptides is essential for comprehending fetal development and potential metabolic programming.

Purpose of the Study:

  • To investigate the developmental timeline of intestinal glucagon-like peptides (GLP) in fetal rats.
  • To characterize the molecular forms of GLP present during gestation and early postnatal life.

Main Methods:

  • Rats were studied from 16 days of gestation to 4 days postnatally.
  • Intestinal peptide content was quantified using radioimmunoassay.
  • Gel filtration chromatography was employed to determine the molecular weights of GLP peptides.

Main Results:

  • Intestinal glucagon-like immunoreactive (GLI) peptide content significantly increased from 0.09 pmol/nmol protein at 16-17 days gestation to 2.8 pmol/nmol protein by 20 days gestation.
  • Two main GLI peptides (11-12 kDa and 5-6 kDa) were detected in fetal rat intestines from 18 days gestation onwards.
  • No significant developmental trends in immunoreactive glucagon (IRGa) were observed, and IRGa peaks were not detected at any age.

Conclusions:

  • The fetal rat intestine exhibits significant maturational development between 17 and 19 days of gestation, leading to the production of GLP peptides.
  • These findings highlight a critical window for GLP development in the fetal gut.
  • The study provides insights into the ontogeny of gut peptides and their potential roles in early development.

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...